|Articles|March 11, 2011

New FDA Information on SYSTEM 1E Liquid Chemical Sterilant Processing

The Food and Drug Administration has changed some statements in its Device Approvals and Clearances section for the SYSTEM 1E Liquid Chemical Sterilant Processing System manufactured by STERIS Corporation.

The revised language reads as follows: "The rinse water is tap (potable) water that has been filtered and exposed to ultraviolet rays. It is treated to minimize bioburden that may be naturally occurring in the water. The treatment method eliminates bacteria/fungi/protozoa from the water. Studies with the test virus MS2 (EPA recommended surrogate for waterborne viruses) showed a 6 log reduction."

To access the FDA document, CLICK HERE.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.